Blood safety strategies for human T-cell lymphotropic virus in Europe

Vox Sanguinis

Volumn 96, Issue 2, 2009, Pages 104-110

  Laperche, S ^a   Worms, B ^b   Pillonel, J ^c  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b Ministry of Health   (France)

^c INSTITUT DE VEILLE SANITAIRE   (France)

Author keywords

Blood donors; Blood transfusion; Europe; HTLV; Leucoreduction

Indexed keywords

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; EUROPE; FINLAND; FRANCE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INFECTION PREVENTION; IRELAND; NETHERLANDS; NORWAY; PRIORITY JOURNAL; ROMANIA; SAFETY; SCANDINAVIA; UNITED KINGDOM; VIRUS DETECTION; VIRUS TRANSMISSION;

BLOOD DONORS; BLOOD TRANSFUSION; ENDEMIC DISEASES; EUROPE; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; MASS SCREENING; PREVALENCE; SAFETY;

EID: 58449121880     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2008.01136.x     Document Type: Article

References (39)

1. Okochi K, Sato H, Hinuma Y : A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang 1984 46 : 245 253
2. Gout O, Baulac M, Gessain A, Semah F, Saal F, Peries J, Cabrol C, Foucault-Fretz C, Laplane D, Sigaux F : Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N Engl J Med 1990 322 : 383 388
3. Donegan E, Busch MP, Galleshaw JA, Shaw GM, Mosley JW : Transfusion of blood components from a donor with human T-lymphotropic virus type II (HTLV-II) infection. The Transfusion Safety Study Group. Ann Intern Med 1990 113 : 555 556
4. Donegan E, Pell P, Lee H, Mosley JW, Shaw GM : Transmission of human T-lymphotropic virus type I by blood components from a donor lacking anti-p24: a case report. The Transfusion Safety Study Group. Transfusion 1992 32 : 68 71
5. Kleinman S, Swanson P, Allain JP, Lee H : Transfusion transmission of human T-lymphotropic virus types I and II: serologic and polymerase chain reaction results in recipients identified through look-back investigations. Transfusion 1993 33 : 14 18
6. Kaplan JE, Litchfield B, Rouault C, Lairmore MD, Luo CC, Williams L, Brew BJ, Price RW, Janssen R, Stoneburner R : HTLV-I-associated myelopathy associated with blood transfusion in the United States: epidemiologic and molecular evidence linking donor and recipient. Neurology 1991 41 : 192 197
7. Manns A, Wilks RJ, Murphy EL, Haynes G, Figueroa JP, Barnett M, Hanchard B, Blattner WA : A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer 1992 51 : 886 891
8. Sullivan MT, Williams AE, Fang CT, Grandinetti T, Poiesz BJ, Ehrlich GD : Transmission of human T-lymphotropic virus types I and II by blood transfusion. A retrospective study of recipients of blood components (1983 through 1988 The American Red Cross HTLV-I/II Collaborative Study Group. Arch Intern Med 1991 151 : 2043 2048
9. Nelson KE, Donahue JG, Munoz A, Cohen ND, Ness PM, Teague A, Stambolis VA, Yawn DH, Callicott B, McAllister H : Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-1 and HTLV-I/II infections. Ann Intern Med 1992 117 : 554 559
10. Inaba S, Okochi K, Sato H, Fukada K, Kinukawa N, Nakata H, Kinjyo K, Fujii F, Maeda Y : Efficacy of donor screening for HTLV-I and the natural history of transfusion-transmitted infection. Transfusion 1999 39 : 1104 1110
11. Kamihira S, Nakasima S, Oyakawa Y, Moriuti Y, Ichimaru M, Okuda H, Kanamura M, Oota T : Transmission of human T cell lymphotropic virus type I by blood transfusion before and after mass screening of sera from seropositive donors. Vox Sang 1987 52 : 43 44
12. Donegan E, Lee H, Operskalski EA, Shaw GM, Kleinman SH, Busch MP, Stevens CE, Schiff ER, Nowicki MJ, Hollingsworth CG : Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1. Transfusion 1994 34 : 478 483
13. Okochi K, Sato H : Adult T-cell leukemia virus, blood donors and transfusion: experience in Japan. Prog Clin Biol Res 1985 182 : 245 256
14. Tokudome S, Tokunaga O, Shimamoto Y, Miyamoto Y, Sumida I, Kikuchi M, Takeshita M, Ikeda T, Fujiwara K, Yoshihara M : Incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic virus type I carriers in Saga, Japan. Cancer Res 1989 49 : 226 228
15. Araujo A, Hall WW : Human T-lymphotropic virus type II and neurological disease. Ann Neurol 2004 56 : 10 19
16. Roucoux DF, Murphy EL : The epidemiology and disease outcomes of human T-lymphotropic virus type II. AIDS Rev 2004 6 : 144 154
17. Orland JR, Engstrom J, Fridey J, Sacher RA, Smith JW, Nass C, Garratty G, Newman B, Smith D, Wang B, Loughlin K, Murphy EL : Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology 2003 61 : 1588 1594
18. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, Shirakawa S, Miyoshi I : Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981 78 : 6476 6480
19. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G : Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985 2 : 407 410
20. Osame M, Usuku K, Izumo S, Gout O, Maurs L, Calender A, de The G : HTLV-I associated myelopathy, a new clinical entity. Lancet 1986 1 : 1031 1032
21. Toro C, Rodes B, Poveda E, Soriano V : Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donor. Transplantation 2003 75 : 102 104
22. Cesaire R, Kerob-Bauchet B, Bourdonne O, Maier H, Amar KO, Halbout P, Dehee A, Desire N, Dantin F, Bera O, Lezin A : Evaluation of HTLV-I removal by filtration of blood cell components in a routine setting. Transfusion 2004 44 : 42 48
23. Vrielink H, Reesink HW : HTLV-I/II prevalence in different geographic locations. Transfus Med Rev 2004 18 : 46 57
24. Paun L, Ispas O, Del Mistro A, Chieco-Bianchi L : HTLV-I in Romania. Eur J Haematol 1994 52 : 117 118
25. Manns A, Hisada M, La Grenade L : Human T-lymphotropic virus type I infection. Lancet 1999 353 : 1951 1958
26. Dougan S, Smith A, Tosswill JC, Davison K, Zuckerman M, Taylor GP : New diagnoses of HTLV infection in England and Wales: 2002-2004. Euro Surveill 2005 10 : 232 235
27. Schreiber GB, Murphy EL, Horton JA, Wright DJ, Garfein R, Chien HC, Nass CC : Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors: the Retrovirus Epidemiology Donor Study. NHLBI Retrovirus Epidemiology Donor Study. J Acquir Immune Defic Syndr Hum Retrovirol 1997 14 : 263 271
28. Van der Bij AK, Coutinho RA, Van der Poel CL : Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands. Transfusion 2006 46 : 1729 1736
29. Courouce AM, Pillonel J, Saura C : Screening of blood donations for HTLV-I/II. Transfus Med Rev 1999 13 : 267 274
30. Pennington J, Taylor GP, Sutherland J, Davis RE, Seghatchian J, Allain JP, Williamson LM : Persistence of HTLV-I in blood components after leukocyte depletion. Blood 2002 100 : 677 681
31. Okochi K, Sato H : Transmission of adult T-cell leukemia virus (HTLV-I) through blood transfusion and its prevention. AIDS Res 1986 2 (Suppl 1 1S157 161
32. Kataoka R, Takehara N, Iwahara Y, Sawada T, Ohtsuki Y, Dawei Y, Hoshino H, Miyoshi I : Transmission of HTLV-I by blood transfusion and its prevention by passive immunization in rabbits. Blood 1990 76 : 1657 1661
33. Chabanel A, Carrat F, Begue S, Masse M, Perrault MP, Andreu G : Quality of leucoreduced red blood cell concentrates: 5 years of follow-up in France. Vox Sang 2008 94 : 41 47
34. Cesaire R, Dehee A, Lezin A, Desire N, Bourdonne O, Dantin F, Bera O, Smadja D, Abel S, Cabie A, Sobesky G, Nicolas JC : Quantification of HTLV type I and HIV type I DNA load in coinfected patients: HIV type 1 infection does not alter HTLV type I proviral amount in the peripheral blood compartment. AIDS Res Hum Retroviruses 2001 17 : 799 805
35. Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham CR, Izumo S, Osame M : Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 1998 4 : 586 593
36. Tynell E, Andersson S, Lithander E, Arneborn M, Blomberg J, Hansson HB, Krook A, Nomberg M, Ramstedt K, Shanwell A, Bjorkman A : Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: cost effectiveness analysis. BMJ 1998 316 : 1417 1422
37. Dodd RY, Notari EP, Stramer SL : Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002 42 : 975 979
38. Stigum H, Magnus P, Samdal HH, Nord E : Human T-cell lymphotropic virus testing of blood donors in Norway: a cost-effect model. Int J Epidemiol 2000 29 : 1076 1084
39. Chabanel A, Andreu G, Carrat F, Herve P : Quality control of leucoreduced cellular blood components in France. Vox Sang 2002 82 : 67 71